Avalo Therapeutics Inc. buy Jefferies Financial Group Inc.
Start price
25.03.25
/
50%
€0.041
Target price
25.03.26
€21.28
Performance (%)
-
End price
26.03.26
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Avalo Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 3,02 % | 2,20 % | 14,66 % |
| iShares Nasdaq 100 | 3,56 % | 1,33 % | 31,41 % |
| iShares Nikkei 225® | 6,62 % | 5,71 % | 49,42 % |
| iShares S&P 500 | 2,64 % | 1,01 % | 25,12 % |
Comments by Jefferies_Financial_ for this prediction
In the thread Avalo Therapeutics Inc. diskutieren
Avalo Therapeutics, Inc. (NASDAQ: AVTX) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $23.00 price target on the stock.
Ratings data for AVTX provided by MarketBeat
In the thread Trading Avalo Therapeutics Inc.
Die von Jefferies_Financial_ gewählte maximale Laufzeit wurde überschritten